Blog

36 Articles

Pancreatic cancer patient Ellen Robbins and her husband Bob
Survivor Stories
November 2, 2022 • 3 Min

Urinary Tract Scans Lead to My Diagnosis

Ellen Robbins has the BRCA2 mutation, and that allowed her to participate in a clinical trial for her pancreatic cancer.

pancreatic cancer long-term survivor Roxanne Waling
Survivor Stories
September 22, 2022 • 1 Min

The Optimist

Roxanne Waling is a long-term survivor of pancreatic cancer, and she credits her integrative oncology team for helping her through.

Long-term pancreatic cancer survivor Helene Avraham-Katz
Survivor Stories
April 28, 2022 • 1 Min

Breathe Happy

When Helene Avraham-Katz was diagnosed with pancreatic cancer, she and her family made the decision to fight it with everything they could.

pancreatic cancer patients Davi D'Agostino and Steven Merlin
Disease Management
January 4, 2022 • 4 Min

Steven Merlin and Davi D’Agostino Team Up to Help Others

Pancreatic cancer patient advocates Steven Merlin and Davi D’Agostino have joined to pool expertise and information for other patients.

microscope on a blue background
Research
December 29, 2021 • 8 Min

Pancreatic Cancer Science—2021 in Review

As the year winds down Let’s Win provides an overall look at the highlights of 2021 in pancreatic cancer science.

pancreatic cancer long-term survivor Helene Avraham-Katz and her family
Survivor Stories
September 23, 2021 • 5 Min

The Butterfly Effect and Living Every Day to My Fullest

Because Helene Avraham-Katz has the BRCA2 mutation, certain chemotherapies work better and she is eligible for specific clinical trials.

pancreatic cancer patient Chris Treubert
Survivor Stories
May 28, 2021 • 3 Min

BRCA Mutation Determines My Pancreatic Cancer Treatment

Chris Treubert started with one type of chemotherapy but when the results of genetic testing showed a BRCA mutation he changed treatment.

abstract DNA image in bright greens and reds
Research
May 25, 2021 • 2 Min

PARP Inhibitor as Maintenance for Pancreatic Cancer Patients with BRCA1, BRCA2, or PALB2 Mutations

A new clinical trial tests a PARP inhibitor as maintenance treatment for pancreatic cancer patients with BRCA1/2 or PALB2 mutations.

pancreatic cancer patient Irma Infante
Survivor Stories
November 30, 2020 • 4 Min

A Second Opinion Makes the Difference

Irma Infante refused to give up after a stage IV pancreatic cancer diagnosis. She went for a second opinion and better treatment options.

pancreatic cancer patient Harvey Parker and his wife and daughters
Survivor Stories
April 24, 2020 • 5 Min

Genetic Testing Leads Me to a PARP Inhibitor Trial

Harvey Parker had genetic testing as part of his initial pancreatic cancer treatment. The BRCA2 mutation led him to a PARP inhibitor clinical trial.

Pancreatic cancer patient Malcolm Robertson and his family
Survivor Stories
April 13, 2020 • 3 Min

A Genetic Mutation Aids My Treatment

Malcolm Robertson carries the BRCA2 mutation, so when he was diagnosed with pancreatic cancer, platinum-based chemo was part of his treatment.

DNA aqua pipette
Research
February 26, 2020 • 6 Min

Exploiting DNA Mutations For Pancreatic Cancer Treatment

Dr. James Cleary explains how the researchers at Dana-Farber are looking to make PARP inhibitors even more effective for pancreatic cancer patients.

Pancreatic cancer patient Davi D'Agostino with student paintings on a river cruise ship
Survivor Stories
February 10, 2020 • 5 Min

My Pancreatic Cancer Clinical Trial Journey

After starting pancreatic cancer treatment, Davi D’Agostino discovered she has the BRCA2 mutation, which made her eligible for a clinical trial.

Pancreatic cancer survivors Scott and Steve Nelson
Survivor Stories
June 6, 2019 • 5 Min

Younger Brother’s Pancreatic Cancer Leads to Regular Screening for his Oldest Brother

When Scott Nelson was diagnosed with pancreatic cancer, oldest brother Steve began regular screening, which lead to his early diagnosis.

pancreatic cancer patient Rick Baker and his wife Shelley
Survivor Stories
May 10, 2019 • 5 Min

Molecular Profiling Leads to Non-Standard Pancreatic Cancer Treatments

With stage IV pancreatic cancer, Rick Baker got molecular profiling which helped direct his different treatments, including clinical trials.